CHNV 汉维科技
7 significant filings since 29 May 2026: 2 on regulatory inquiry, 2 on major holder selling and 1 on earnings pre-announcement, and 2 other kinds. The latest, on 10 Aug 2026: 股东拟减持股份的预披露公告. On 14 Jul 2026 the company said it expects net profit for the period ending 30 Jun 2026 to rise by 1,601.50% to 2,102.00% from the same period a year earlier.
自 29 May 2026 起有 7 份重大公告：regulatory inquiry 2 份、major holder selling 2 份、earnings pre-announcement 1 份，另有 2 类。最新一份（10 Aug 2026）：股东拟减持股份的预披露公告。14 Jul 2026 公司预告截至 30 Jun 2026 的净利润较上年同期上升 1,601.50% 至 2,102.00%。
| Measure 指标 | This Company 本公司 | Peer Median 同业中值 | Standing 排位 | |
|---|---|---|---|---|
| Market Cap 市值 | ¥10亿 | ¥46亿 | 5th lowest of 185 · 185 家中第 5 低 | |
| Trailing P/E 市盈率 | 57.8x | 39.8x | 43rd highest of 147 · 147 家中第 43 高 | |
| P/B 市净率 | 2.6x | 2.3x | 79th highest of 185 · 185 家中第 79 高 | |
| Revenue Growth 营收增速 | 10.4% | 13.2% | 82nd lowest of 185 · 185 家中第 82 低 | |
| Profit Growth 净利增速 | 1,615.0% | 4.1% | 2nd highest of 185 · 185 家中第 2 高 | |
| Gross Margin 毛利率 | 13.0% | 22.5% | 40th lowest of 185 · 185 家中第 40 低 | |
| Net Margin 净利率 | 3.6% | 6.3% | 64th lowest of 185 · 185 家中第 64 低 | |
| Return on Equity 净资产收益率 | 3.0% | 2.9% | 83rd highest of 184 · 184 家中第 83 高 | |
| Debt to Assets 资产负债率 | 36.8% | 31.4% | 74th highest of 185 · 185 家中第 74 高 | |
| Grade Score 评级得分 | 44 | 50 | 68th lowest of 185 · 185 家中第 68 低 |
Statement figures are for the period to 30 Jun 2026, filed by 185 of 185 peers. A rank needs 5 or more peers with a value. A company with no earnings has no P/E. 报表数据为截至 30 Jun 2026 的期间，185 家同业中 185 家已披露。排位至少需要 5 家有数据的同业；无盈利的公司没有市盈率。
| Peer 同业 | Market Cap | P/E | P/B | Revenue Growth | Net Margin | ROE | Grade |
|---|---|---|---|---|---|---|---|
| Wanhua 万华化学 | ¥2,174亿 | 13.2x | 1.9x | 31.3% | 9.7% | 9.0% | C |
| Zhejiang Juhua 巨化股份 | ¥917亿 | 20.9x | 4.2x | 0.1% | 22.3% | 12.2% | C |
| Zhejiang NHU 新和成 | ¥790亿 | 11.0x | 2.3x | 18.3% | 30.7% | 11.4% | C |
| Haohua Chemical Science & Technology 昊华科技 | ¥582亿 | 34.2x | 3.1x | 24.9% | 10.8% | 4.8% | C |
| Zhejiang Longsheng 浙江龙盛 | ¥395亿 | 20.7x | 1.2x | 12.1% | 14.0% | 3.1% | C |
| Hoshine Silicon 合盛硅业 | ¥377亿 | — | 1.3x | 3.9% | 3.1% | 1.1% | D |
| Do-Fluoride New Materials 多氟多 | ¥368亿 | 54.7x | 4.2x | 62.5% | 8.2% | 5.9% | C |
| Sanmei 三美股份 | ¥305亿 | 14.3x | 3.6x | 20.7% | 30.7% | 12.6% | C |
| Cathay Biotech 凯赛生物 | ¥277亿 | 44.3x | 1.6x | 13.7% | 19.5% | 2.1% | C |
| Adisseo 安迪苏 | ¥249亿 | 18.9x | 1.3x | 14.0% | 9.3% | 4.5% | C |
| Hangzhou Oxygen Plant Group 杭氧股份 | ¥244亿 | 23.6x | 2.4x | 18.6% | 7.1% | 5.6% | C |
| Guangdong Hongda Holdings Group 广东宏大 | ¥215亿 | 22.1x | 3.0x | 10.8% | 8.4% | 7.5% | D |
| Xizang Gaozheng Civil Explosives 高争民爆 | ¥212亿 | 131.6x | 19.9x | -5.2% | 4.1% | 3.0% | D |
| Meihua Bio 梅花生物 | ¥206亿 | 9.5x | 1.3x | -0.4% | 5.4% | 4.0% | D |
| CHNV 汉维科技 | ¥10亿 | 57.8x | 2.6x | 10.4% | 3.6% | 3.0% | D |
Peers are listed by market cap, with this company highlighted. 同业按市值排列，本公司高亮显示。